Presentations

Hope in the Pipeline: New Drugs (Bedaquiline/Sirturo, Delamanid/Deltyba)

Description
Derek Ambrosino, senior communications specialist for the TB Alliance, tells of the latest findings in drugs that may become the cure for specific diseases, during the 2014 #J2JLungHealth Media Training in Barcelona. http://nationalpress.org/programs-and-resources/program/lung-health-media-training-barcelona-spain-2014/
Categories
Published
of 24
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  TB Alliance Promise in the Pipeline October 29, 2014  TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.  TB Alliance: Promise in the Pipeline ã Arsenal of drugs developed mostly in 1960s Old ã TB treatment today takes 6-30 months Long ã Many pills must be taken daily; Drug-resistant treatment includes daily injections Complex ã Drug-resistant TB treatment can cost > $10,000 Expensive ã Long & complex; breeds resistance & default; incompatible with some HIV treatments; MDR-TB treatment often fails Inadequate Current TB Therapy 3  TB Alliance Vision Success will require novel drug combinations Current Treatment 6-30  Months New Treatments in Development 2-4  Months Aspirational Goal 7-10  Days TB Alliance: Promise in the Pipeline 4
Search
Tags
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks